Ibsrela (tenapanor) and Linzess (linaclotide) are commonly prescribed treatments for irritable bowel syndrome with ...

Mirum Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of LIVMARLI® (maralixibat) for the treatment of cholestatic pruritus ...

SB 1211, which passed the legislature earlier this session, permits the sale or purchase of ivermectin "suitable for human ...

These scripts for confident client conversations are compassionate and provide options to help ease pet owners’ concerns ...

PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

To make it easier to remember, Clark recommends pairing your B12 supplement with an existing habit, like brushing your teeth ...

(Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today ...

The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans has launched a new fund to assist individuals living with ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

Daewoong Pharmaceutical has renewed its package of over-the-counter drugs 'Impactamine Tablets 12T' specialized in improving ...